Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Book Building
₹ 1856.74
₹ 679
22
₹ 14,938.00
MumbaiNSE
30-Jul-2024
01-Aug-2024
06-Aug-2024
1 Week | -5.86 |
1 Month | -3.50 |
3 Month | -33.05 |
Initial public offer of 27,368,151* equity shares of face value of Rs. 2 each (Equity Shares) of Akums Drugs and Pharmaceuticals Limited (Company or Issuer) for cash at a price of Rs. 679^ per equity share (including a share premium of Rs. 677 per equity share) (Offer Price) aggregating to Rs. 1856.74 crores*^ comprising a fresh issue of 10,037,716* equity shares aggregating to Rs. 680.00*^ crores by the company (Fresh Issue) and an offer for sale of 17,330,435 equity shares aggregating to Rs. 1176.74 crores* (Offered Shares) by the selling shareholders, comprising of 1,512,000 equity shares aggregating to Rs. 102.67 crores* by Sanjeev Jain, 1,512,000 equity shares aggregating to Rs. 102.67 crores* by Sandeep Jain (together the Promoter Selling Shareholders) and 14,306,435 equity shares aggregating to Rs. 971.41 crores* by Ruby QC Investment Holdings Pte. Ltd. (The Investor Selling Shareholder) (the promoter selling shareholders and the investor selling shareholder, collectively referred to as the Selling Shareholders) (Offer for Sale, together with the fresh issue, the Offer). This offer includes a reservation of 243,902* equity shares aggregating to Rs. 15.00 crores*^ for subscription by eligible employees (the Employee Reservation Portion). The offer less the employee reservation portion is hereinafter referred to as the Net Offer. The offer and the net offer constituted 17.39% and 17.23% of its post-offer paid-up equity share capital, respectively. The face value of equity shares is Rs. 2 each. The offer price is 339.50 times the face value of the equity shares. *Subject to finalization of basis of allotment ^After employee discount.
Repayment/prepayment of all or certain borrowings of the company and subsidiary. Funding incremental working capital requirements of the company. Pursuing inorganic growth initiatives through acquisitions. General corporate purposes.
Akums Drugs & Pharmaceuticals Ltd, C-101 247 Park, L B S Marg, Vikhroli West, Mumbai-400083
Phone - 91-22-49186000
Fax - 91-22-49186060
Email - cs@akums.net
Website - www.akums.in